 |
 |
 |
 |
|
 |
 |
clinically significant attitudinal change. Am J Psychiatry 1993; 150:770.
Golden RN, Rudarfer MV, Sherer MA, et al. Bupropion in depression: I. Biochemical effects and
clinical response. Arch Gen Psychiatry 1988; 45:139.
Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in
obsessive compulsive disorder: a meta-analysis. Arch Gen Psychiatry 1995; 52:53.
Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus
placebo in the treatment of dysthymia. Am J Psychiatry 1993; 150:1169.
Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind placebo
controlled crossover study. Am J Psychiatry 1995; 152:1368.
Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in
diabetic neuropathy. N Engl J Med 1992; 326:1250.
Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a
randomized, double-blind placebo-controlled study. Br J Psychiatry 1995; 167:374.
Quitkin FM, Stewart JW, McGrath PJ, et al. Phenelzine versus imipramine in treatment of probable
atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988;
145:306.
Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients. Brain 1984; 107:81.
Robinson RG, Parikh RM, Lipsey JR, et al. Pathological laughing and crying following stroke:
validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 1993; 150:286.
Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors
and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735.
Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar
depression. J Clin Psychiatry 1994; 55:391.
Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers
with borderline personality disorders. J Clin Psychopharmacol 1995; 15:23.
Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J
Psychiatry 1985; 142:430.
Steiner M. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995; 332:1529.
Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and
desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989; 321:497.
Walsh ВТ, Stewart JW, Roose SP, et al. Treatment of bulimia with phenelzine. Arch Gen Psychiatry
1984; 41:1105.
Yonkers KA, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric
disorder with sertraline. JAMA 1997; 278:983.
Zisook S, Braff DL, Click MA. Monoamine oxidase inhibitors in the treatment of atypical depression. J
Clin Psychopharmacol 1985; 5:31.
Применение
Fontaine R, Ontiveros H, Elie R, et al. A double-blind comparison of nefazodone, imipramine, and
placebo in major depression. J Clin Psychiatry 1994; 55:234.
Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine
augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993; 50:387.
Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent
depression. Arch Gen Psychiatry 1992; 49:769.
Quitkin FM, Rabkin JG, Ross D, et al. Identification of true drug response to antidepressants. Arch Gen
Psychiatry 1984; 41:782.
Quitkin FM, Stewart JW, McGrath PJ, et al. Loss of drug effects during continuation therapy. Am J
Psychiatry 1993; 150:562.
Renaud J, Axelson D, Birmaher B. A risk-benefit assessment of pharmacotherapies for clinical
depression in children and adolescents. Drug Safety 1999; 20:59.
Task Force on the Use of Laboratory Tests in Psychiatry, American Psychiatric Association. Tricyclic
antidepressants: blood level measurements and clinical outcome. Am J Psychiatry 1985; 142:155.
Побочные эффекты
